Gilbert & Cook, Inc.

Position in DNLI — Denali Therapeutics Inc.

CIK 1675762 WEST DES MOINES, IA

Position in DNLI

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$287,523

+$78,800 QoQ

Shares Held

11,179

+2.8% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#185

of 290 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Gilbert & Cook, Inc. holds $5,438,299 across 5 Biotechnology names. DNLI ranks #5 (5.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	8,543	$2,278,588
2	ARGX	Argenx SE	1,291	$1,197,751
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,928	$1,182,445
4	GPCR	Structure Therapeutics Inc.	9,167	$491,992
5	DNLI	Denali Therapeutics Inc. This page	11,179	$287,523

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$287,523	11,179	+2.8%	Shares	Sole	2026-07-28
2026-03-31	$208,723	10,871	—	Shares	Sole	2026-05-05
No filing history on record for this holder in this stock.